Vanda Pharmaceuticals
VNDA
$4.78
Share price
3.57%
Change (1 day)
-22.07%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.10 B
According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are $0.10 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -3.29% |
| 2022-12-31 | $0.10 B | 20.46% |
| 2021-12-31 | $88.86 M | 10.82% |
| 2020-12-31 | $80.19 M | 10.15% |
| 2019-12-31 | $72.8 M | 28.38% |
| 2018-12-31 | $56.7 M | -23.41% |
| 2017-12-31 | $74.03 M | -6.33% |
| 2016-12-31 | $79.04 M | -1.22% |
| 2015-12-31 | $80.02 M | 635.03% |
| 2014-12-31 | $10.88 M | -89.03% |
| 2013-12-31 | $99.22 M | -20.96% |
| 2012-12-31 | $0.12 B | -15.82% |
| 2011-12-31 | $0.14 B | -14.95% |
| 2010-12-31 | $0.17 B | -13.48% |
| 2009-12-31 | $0.20 B | 5078.98% |
| 2008-12-31 | $3.91 M | -70.2% |
| 2007-12-31 | $13.13 M | 38.18% |
| 2006-12-31 | $9.5 M | 86.78% |
| 2005-12-31 | $5.08 M | 181.31% |
| 2004-12-31 | $1.8 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 95,315.82% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 52,617.09% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 132,434.53% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | 51,230.63% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 66,585.98% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 79,570.63% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $1.44 M | -98.61% | 🇺🇸 USA |